Skip to content

ADOCS: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ADOCS

BE 0460.848.186
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€35,410
2024 · -€8,882+€44,292
Equity
€476,307
2024 · €514,896-€38,590
Cash
€9,735
2024 · €13,575-€3,840
Balance sheet total
€717,403
2024 · €793,576-€76,173

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€40,338

    down €40,338 (-5.4%), from €741,396 to €701,058

  • Current investments -€34,551

    down €34,551 (-100.0%), from €34,551 to €0

Equity and liabilities
  • Reserves -€38,590

    down €38,590 (-9.1%), from €423,681 to €385,091

    of which Distributable reserves: -€28,084

  • Debts after one year -€16,668

    down €16,668 (-12.2%), from €136,615 to €119,947

    of which Financial debts: -€16,668

  • Current portion of long-term debt -€16,665

    down €16,665 (-50.0%), from €33,333 to €16,668

Income statement
  • Financial income +€43,980

    up €43,980 (+10040.6%), from €438 to €44,418

    of which Financial income: +€43,980

  • Depreciation -€7,218

    down €7,218 (-15.2%), from €47,556 to €40,338

  • Taxes +€5,712

    new in 2025: €5,712

  • Gross operating margin -€1,472

    down €1,472 (-3.1%), from €47,408 to €45,936

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€8,882
Gross operating margin -€1,472
Depreciation +€7,218
Other operating charges -€189
Financial income +€43,980
Financial charges +€467
Taxes -€5,712
Result 2025 €35,410

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€68,943
Investment +€34,551
Financing -€107,333
Cash 2024 €13,575
Net result for the year +€35,410
Depreciation +€40,338
Receivables within one year -€2,538
Smaller working-capital items +€111
Provisions -€3,502
Tax, wage and social debts +€3,212
Accrued charges and deferred income -€4,088
Current investments +€34,551
Debts after one year -€16,668
Current portion of long-term debt -€16,665
Contributions, distributions and other -€74,000
Cash 2025 €9,735
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €793,576 €717,403 -€76,173 -9.6%
Fixed assets 21/28 €741,396 €701,058 -€40,338 -5.4%
Tangible fixed assets 22/27 €741,396 €701,058 -€40,338 -5.4%
Land and buildings 22 €741,396 €701,058 -€40,338 -5.4%
Financial fixed assets 28 €0 - =
Current assets 29/58 €52,180 €16,344 -€35,835 -68.7%
Amounts receivable within one year 40/41 €3,567 €6,106 +€2,538 +71.2%
Trade receivables 40 - €2,670 +€2,670
Other amounts receivable 41 €3,567 €3,436 -€131 -3.7%
Current investments 50/53 €34,551 €0 -€34,551 -100.0%
Cash at bank and in hand 54/58 €13,575 €9,735 -€3,840 -28.3%
Deferred charges and accrued income 490/1 €486 €503 +€17 +3.5%
Total equity and liabilities 10/49 €793,576 €717,403 -€76,173 -9.6%
Equity 10/15 €514,896 €476,307 -€38,590 -7.5%
Contributions 10/11 €91,215 €91,215 = 0.0%
Reserves 13 €423,681 €385,091 -€38,590 -9.1%
Tax-exempt reserves 132 €191,722 €181,217 -€10,505 -5.5%
Distributable reserves 133 €231,959 €203,874 -€28,084 -12.1%
Profit (loss) carried forward 14 - €0 =
Provisions and deferred taxes 16 €63,907 €60,406 -€3,502 -5.5%
Deferred taxes 168 €63,907 €60,406 -€3,502 -5.5%
Amounts payable 17/49 €214,772 €180,690 -€34,081 -15.9%
Amounts payable after more than one year 17 €136,615 €119,947 -€16,668 -12.2%
Financial debts 170/4 €113,515 €96,847 -€16,668 -14.7%
Other amounts payable 178/9 €23,100 €23,100 = 0.0%
Amounts payable within one year 42/48 €42,399 €29,074 -€13,325 -31.4%
Current portion of amounts payable after more than one year 42 €33,333 €16,668 -€16,665 -50.0%
Trade debts 44 €1,475 €1,603 +€128 +8.7%
Suppliers 440/4 €1,475 €1,603 +€128 +8.7%
Taxes, remuneration and social security 45 - €3,212 +€3,212
Taxes 450/3 - €3,212 +€3,212
Other amounts payable 47/48 €7,591 €7,591 = 0.0%
Accrued charges and deferred income 492/3 €35,757 €31,669 -€4,088 -11.4%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €47,556 €40,338 -€7,218 -15.2%
Other operating charges 640/8 €3,550 €3,739 +€189 +5.3%
Gross operating margin 9900 €47,408 €45,936 -€1,472 -3.1%
Operating profit (loss) 9901 -€3,698 €1,859 +€5,557
Financial income 75/76B €438 €44,418 +€43,980 +10040.6%
Recurring financial income 75 €438 €44,418 +€43,980 +10040.6%
Non-recurring financial income 76B €0 - =
Financial charges 65/66B €9,124 €8,657 -€467 -5.1%
Recurring financial charges 65 €9,124 €8,657 -€467 -5.1%
Profit (loss) for the period before taxes 9903 -€12,384 €37,620 +€50,004
Transfer from deferred taxes 780 €3,502 €3,502 = 0.0%
Income taxes 67/77 - €5,712 +€5,712
Profit (loss) for the period 9904 -€8,882 €35,410 +€44,292
Transfer from tax-exempt reserves 789 €10,505 €10,505 = 0.0%
Profit (loss) for the period to be appropriated 9905 €1,623 €45,916 +€44,292 +2728.6%

Source: filed annual accounts (NBB), fiscal years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.